• Je něco špatně v tomto záznamu ?

Integrin expression and adhesivity to fibronectin in primary acute myeloid leukemia cells: Impact of NPM1 and FLT3 mutations

K. Kuželová, A. Obr, J. Marková, Z. Gašová

. 2020 ; 105 (5) : 578-587. [pub] 20200811

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21026446

Grantová podpora
16-16169S Grantová Agentura České Republiky
00023736 Ministerstvo Zdravotnictví Ceské Republiky

OBJECTIVES: Interaction of leukemia cells with the bone marrow extracellular matrix promotes cell survival and resistance to chemotherapy. In this work, we analyzed integrin expression and adhesivity to fibronectin in primary cells from patients with acute myeloid leukemia. METHODS: Surface expression of integrins β1 and αVβ3 on primary leukemia cells (N = 46) was correlated with the stem cell marker CD34, as well as with cell adhesivity to fibronectin. The results were analyzed with regard to the mutational status of NPM1 and FLT3 genes. RESULTS: The integrin β1 was omnipresent, whereas αVβ3 was often more expressed on CD34-positive cells. In particular, higher αVβ3 expression on CD34+ cells was associated with NPM1 mutation (P = .0018). Monocytic leukemias had significantly higher αVβ3 expression compared to less maturated cases (P = .0008). Cells from patients with internal tandem duplications in FLT3 (FLT3-ITD) had lower adhesivity to fibronectin compared to cells with wild-type FLT3 (P = .031), specifically in less differentiated myeloblasts. Inhibition of a putative FLT3-ITD target, EZH2, increased cell adhesivity in MV4-11 cell line (P = .024). CONCLUSIONS: The integrin αVβ3 is expressed in particular on CD34+ cells with NPM1 mutation and might have a prognostic value in patients with mutated NPM1. FLT3-ITD is associated with lower cell adhesivity, especially in patients with less differentiated leukemias.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21026446
003      
CZ-PrNML
005      
20211026132913.0
007      
ta
008      
211013s2020 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/ejh.13488 $2 doi
035    __
$a (PubMed)32668024
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Kuželová, Kateřina $u Department of Proteomics, Institute of Hematology and Blood Transfusion, Prague 2, Czech Republic
245    10
$a Integrin expression and adhesivity to fibronectin in primary acute myeloid leukemia cells: Impact of NPM1 and FLT3 mutations / $c K. Kuželová, A. Obr, J. Marková, Z. Gašová
520    9_
$a OBJECTIVES: Interaction of leukemia cells with the bone marrow extracellular matrix promotes cell survival and resistance to chemotherapy. In this work, we analyzed integrin expression and adhesivity to fibronectin in primary cells from patients with acute myeloid leukemia. METHODS: Surface expression of integrins β1 and αVβ3 on primary leukemia cells (N = 46) was correlated with the stem cell marker CD34, as well as with cell adhesivity to fibronectin. The results were analyzed with regard to the mutational status of NPM1 and FLT3 genes. RESULTS: The integrin β1 was omnipresent, whereas αVβ3 was often more expressed on CD34-positive cells. In particular, higher αVβ3 expression on CD34+ cells was associated with NPM1 mutation (P = .0018). Monocytic leukemias had significantly higher αVβ3 expression compared to less maturated cases (P = .0008). Cells from patients with internal tandem duplications in FLT3 (FLT3-ITD) had lower adhesivity to fibronectin compared to cells with wild-type FLT3 (P = .031), specifically in less differentiated myeloblasts. Inhibition of a putative FLT3-ITD target, EZH2, increased cell adhesivity in MV4-11 cell line (P = .024). CONCLUSIONS: The integrin αVβ3 is expressed in particular on CD34+ cells with NPM1 mutation and might have a prognostic value in patients with mutated NPM1. FLT3-ITD is associated with lower cell adhesivity, especially in patients with less differentiated leukemias.
650    _2
$a buněčná adheze $7 D002448
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a buněčná membrána $x metabolismus $7 D002462
650    _2
$a fibronektiny $x metabolismus $7 D005353
650    _2
$a duplikace genu $7 D020440
650    _2
$a exprese genu $7 D015870
650    _2
$a lidé $7 D006801
650    _2
$a integriny $x genetika $x metabolismus $7 D016023
650    _2
$a akutní myeloidní leukemie $x genetika $x metabolismus $7 D015470
650    _2
$a mutace $7 D009154
650    _2
$a jaderné proteiny $x genetika $x metabolismus $7 D009687
650    _2
$a vazba proteinů $7 D011485
650    _2
$a tyrosinkinasa 3 podobná fms $x genetika $x metabolismus $7 D051941
655    _2
$a časopisecké články $7 D016428
700    1_
$a Obr, Adam $u Department of Proteomics, Institute of Hematology and Blood Transfusion, Prague 2, Czech Republic
700    1_
$a Marková, Jana $u Clinical Department, Institute of Hematology and Blood Transfusion, Prague 2, Czech Republic
700    1_
$a Gašová, Zdenka $u Department of Apheresis, Institute of Hematology and Blood Transfusion, Prague 2, Czech Republic
773    0_
$w MED00001620 $t European journal of haematology $x 1600-0609 $g Roč. 105, č. 5 (2020), s. 578-587
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32668024 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20211026132919 $b ABA008
999    __
$a ok $b bmc $g 1715230 $s 1146953
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 105 $c 5 $d 578-587 $e 20200811 $i 1600-0609 $m European journal of haematology $n Eur J Haematol $x MED00001620
GRA    __
$a 16-16169S $p Grantová Agentura České Republiky
GRA    __
$a 00023736 $p Ministerstvo Zdravotnictví Ceské Republiky
LZP    __
$a Pubmed-20211013

Najít záznam

Citační ukazatele

Možnosti archivace